Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cofilin 1 pseudogene refers to a nonfunctional DNA sequence that resembles the functional cofilin 1 gene but has acquired mutations or features (such as disruption of coding sequence, lack of regulatory regions, or truncations) that prevent the production of a functional protein[3][1]. Pseudogenes like this one are typically remnants of former genes that arose through gene duplication and subsequent degeneration, or through retrotransposition events[3][1][2]. They ordinarily do not have a biological role or known impact on disease, and are not the subject of therapeutic development or drug targeting. In genomics databases, they are annotated primarily for completeness but are not considered molecular drug targets[3][1]. If you need structured information for targets of pharmacological interest, this pseudogene would not qualify, and it should be flagged as "incorrect" for such purposes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cofilin 1 pseudogene.